{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:53:50Z","timestamp":1790394830722,"version":"4.1.0"},"reference-count":305,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["103191\/A\/13\/Z"],"award-info":[{"award-number":["103191\/A\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107116\/Z\/15\/Z"],"award-info":[{"award-number":["107116\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2017.00405","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T04:23:44Z","timestamp":1512620624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Andrew P.","family":"Tosolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Sleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3109\/21678421.2014.959024","article-title":"Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.","volume":"15","author":"Abe","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/hmg\/dds540","article-title":"Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.","volume":"22","author":"Ackermann","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/104303402753812458","article-title":"Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.","volume":"13","author":"Acsadi","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.","volume":"13","author":"Al-Chalabi","year":"2014","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1136\/jnnp.2010.207464","article-title":"An estimate of amyotrophic lateral sclerosis heritability using twin data.","volume":"81","author":"Al-Chalabi","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","article-title":"The epidemiology of ALS: a conspiracy of genes, environment and time.","volume":"9","author":"Al-Chalabi","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/srep25960","article-title":"Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS.","volume":"6","author":"Allodi","year":"2016","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1468-1331.2009.02586.x","article-title":"Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.","volume":"16","author":"Alonso","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","article-title":"p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND\/ALS.","volume":"122","author":"Al-Sarraj","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-9-37","article-title":"The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.","volume":"9","author":"Andersson","year":"2008","journal-title":"BMC Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mt.2014.180","article-title":"Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.","volume":"23","author":"Ayers","year":"2015","journal-title":"Mol. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/hmg\/9.5.803","article-title":"Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2.","volume":"9","author":"Azzouz","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.","volume":"114","author":"Azzouz","year":"","journal-title":"J. Clin. Invest."},{"key":"B14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.","volume":"429","author":"Azzouz","year":"","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nbd.2016.03.027","article-title":"Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: where have we been and what have we learned?","volume":"97","author":"Bartus","year":"","journal-title":"Neurobiol. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.03.026","article-title":"Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: where do we stand and where must we go next?","volume":"97","author":"Bartus","year":"","journal-title":"Neurobiol. Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399410001523","article-title":"The role of RNA processing in the pathogenesis of motor neuron degeneration.","volume":"12","author":"B\u00e4umer","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000773","article-title":"Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.","volume":"5","author":"B\u00e4umer","year":"2009","journal-title":"PLOS Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/0141076813511451","article-title":"Advances in motor neurone disease.","volume":"107","author":"B\u00e4umer","year":"2014","journal-title":"J. R. Soc. Med."},{"key":"B20","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1523\/JNEUROSCI.17-17-06504.1997","article-title":"Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population.","volume":"17","author":"Baumgartner","year":"1997","journal-title":"J. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","article-title":"A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?","volume":"17","author":"Bellingham","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2006.12.015","article-title":"Lost in translation: treatment trials in the SOD1 mouse and in human ALS.","volume":"26","author":"Benatar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12031-015-0695-2","article-title":"Multifactorial gene therapy enhancing the glutamate uptake system and reducing oxidative stress delays symptom onset and prolongs survival in the SOD1-G93A ALS mouse model.","volume":"58","author":"Benkler","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.ymthe.2017.05.017","article-title":"A new AAV10-U7-mediated gene therapy prolongs survival and restores function in an ALS mouse model.","volume":"25","author":"Biferi","year":"2017","journal-title":"Mol. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1212\/WNL.0b013e318249f697","article-title":"SMN1 gene duplications are associated with sporadic ALS.","volume":"78","author":"Blauw","year":"2012","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E5863","DOI":"10.1073\/pnas.1509758112","article-title":"Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II\/III spinal muscular atrophy.","volume":"112","author":"Bogdanik","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia.","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/hmg\/10.18.1925","article-title":"Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice.","volume":"10","author":"Bordet","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.2015.122","article-title":"Therapeutic rAAVrh10 mediated SOD1 silencing in adult SOD1G93A mice and nonhuman primates.","volume":"27","author":"Borel","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/nn.2660","article-title":"Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.","volume":"13","author":"Bosco","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1242\/dmm.030148","article-title":"Therapeutic strategies for spinal muscular atrophy: SMN and beyond.","volume":"10","author":"Bowerman","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww033","article-title":"NEK1 mutations in familial amyotrophic lateral sclerosis.","volume":"139","author":"Brenner","year":"2016","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis.","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/hum.2012.218","article-title":"scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.","volume":"24","author":"Bucher","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1073858414561795","article-title":"SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes.","volume":"21","author":"Bunton-Stasyshyn","year":"2015","journal-title":"Neuroscientist"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2014.03.005","article-title":"The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.","volume":"256","author":"Butchbach","year":"2014","journal-title":"Exp. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/jnnp-2011-301530","article-title":"Absence of consensus in diagnostic criteria for familial neurodegenerative diseases.","volume":"83","author":"Byrne","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/cns.12242","article-title":"Gem depletion: amyotrophic lateral sclerosis and spinal muscular atrophy crossover.","volume":"20","author":"Cauchi","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1083\/jcb.201510032","article-title":"Defective control of pre-messenger RNA splicing in human disease.","volume":"212","author":"Chabot","year":"2016","journal-title":"J. Cell Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00476","article-title":"Improving the delivery of SOD1 antisense oligonucleotides to motor neurons using calcium phosphate-lipid nanoparticles.","volume":"11","author":"Chen","year":"2017","journal-title":"Front. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/mt.2012.100","article-title":"Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease.","volume":"20","author":"Chen","year":"2012","journal-title":"Mol. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review.","volume":"10","author":"Chi\u00f2","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"B46","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy.","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","article-title":"Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.","volume":"347","author":"Cirulli","year":"2015","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1471-4159.2009.06383.x","article-title":"TDP-43 is recruited to stress granules in conditions of oxidative insult.","volume":"111","author":"Colombrita","year":"2009","journal-title":"J. Neurochem."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17820","article-title":"The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains.","volume":"5","author":"Conlon","year":"2016","journal-title":"Elife"},{"key":"B50","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ejhg.2011.255","article-title":"Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.","volume":"20","author":"Corcia","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s12031-014-0426-0","article-title":"Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALS.","volume":"55","author":"Dadon-Nachum","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ajhg.2014.12.009","article-title":"Improvement of SMN2 pre-mRNA processing mediated by exon-specific U1 small nuclear RNA.","volume":"96","author":"Dal Mas","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/jnr.21636","article-title":"Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6\/1 mice.","volume":"86","author":"Denovan-Wright","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/acn3.162","article-title":"SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice.","volume":"2","author":"Dirren","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/mt.2008.60","article-title":"Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity.","volume":"16","author":"Dodge","year":"2008","journal-title":"Mol. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/mt.2010.206","article-title":"AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.","volume":"18","author":"Dodge","year":"2010","journal-title":"Mol. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ana.24332","article-title":"A large animal model of spinal muscular atrophy and correction of phenotype.","volume":"77","author":"Duque","year":"2015","journal-title":"Ann. Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2016.11.033","article-title":"The antisense transcript SMN-AS1 regulates SMN expression and is a novel therapeutic target for spinal muscular atrophy.","volume":"93","author":"d\u2019Ydewalle","year":"2017","journal-title":"Neuron"},{"key":"B63","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/acn3.335","article-title":"\u03b1CAR IGF-1 vector targeting of motor neurons ameliorates disease progression in ALS mice.","volume":"3","author":"Eleftheriadou","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders.","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jpeds.2012.05.067","article-title":"Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy.","volume":"162","author":"Farrar","year":"2013","journal-title":"J. Pediatr."},{"key":"B66","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.nbd.2011.08.018","article-title":"Gene therapy for amyotrophic lateral sclerosis.","volume":"48","author":"Federici","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/gt.2011.130","article-title":"Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs.","volume":"19","author":"Federici","year":"2012","journal-title":"Gene Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/hmg\/ddi168","article-title":"Gemins modulate the expression and activity of the SMN complex.","volume":"14","author":"Feng","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/hmg\/ddv629","article-title":"Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.","volume":"25","author":"Feng","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy.","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0092-8674(00)80368-2","article-title":"The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.","volume":"90","author":"Fischer","year":"1997","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/srep37968","article-title":"Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis.","volume":"6","author":"Fogarty","year":"2016","journal-title":"Sci. Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1523\/JNEUROSCI.3483-14.2015","article-title":"Motor cortex layer V pyramidal neurons exhibit dendritic regression, spine loss, and increased synaptic excitation in the presymptomatic hSOD1G93A mouse model of amyotrophic lateral sclerosis.","volume":"35","author":"Fogarty","year":"2015","journal-title":"J. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/acn3.375","article-title":"Additive amelioration of ALS by co-targeting independent pathogenic mechanisms.","volume":"4","author":"Frakes","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.nbd.2008.12.003","article-title":"Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.","volume":"33","author":"Franz","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","article-title":"Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia.","volume":"18","author":"Freischmidt","year":"2015","journal-title":"Nat. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1242\/jcs.02692","article-title":"TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines.","volume":"118","author":"Fujii","year":"2005","journal-title":"J. Cell Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2478\/v10134-010-0045-4","article-title":"Treatment strategies for spinal muscular atrophy.","volume":"1","author":"Fuller","year":"2010","journal-title":"Transl. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jnc.13945","article-title":"Linking amyotrophic lateral sclerosis and spinal muscular atrophy through RNA-transcriptome homeostasis: a genomics perspective.","volume":"141","author":"Gama-Carvalho","year":"2017","journal-title":"J. Neurochem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.drudis.2013.10.014","article-title":"Moving forward in clinical trials for ALS: motor neurons lead the way please.","volume":"19","author":"Gen\u00e7","year":"2014","journal-title":"Drug Discov. Today"},{"key":"B86","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nbd.2013.03.003","article-title":"Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm.","volume":"55","author":"Gerbino","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/NEN.0b013e318244b635","article-title":"Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.","volume":"71","author":"Gertz","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/hum.2011.166","article-title":"Decreasing disease severity in symptomatic, Smn-\/-;SMN2+\/+, spinal muscular atrophy mice following scAAV9-SMN delivery.","volume":"23","author":"Glascock","year":"","journal-title":"Hum. Gene Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbrc.2011.11.121","article-title":"Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy.","volume":"417","author":"Glascock","year":"","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"545","DOI":"10.15252\/emmm.201607199","article-title":"Delivery is key: lessons learnt from developing splice-switching antisense therapies.","volume":"9","author":"Godfrey","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1523\/JNEUROSCI.5775-11.2012","article-title":"Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction.","volume":"32","author":"Gogliotti","year":"2012","journal-title":"J. Neurosci."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/845345","article-title":"Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice.","volume":"2013","author":"Gotkine","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B93","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/bies.201100082","article-title":"Invertebrate models of spinal muscular atrophy: insights into mechanisms and potential therapeutics.","volume":"33","author":"Grice","year":"2011","journal-title":"Bioessays"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1093\/hmg\/ddt222","article-title":"ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.","volume":"22","author":"Groen","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00412-017-0637-6","article-title":"UsnRNP biogenesis: mechanisms and regulation.","volume":"126","author":"Gruss","year":"2017","journal-title":"Chromosoma"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"B97","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm0497-429","article-title":"Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors.","volume":"3","author":"Haase","year":"1997","journal-title":"Nat. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/S0022-510X(98)00207-X","article-title":"Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action.","author":"Haase","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0883073815627882","article-title":"Intrathecal injections in children with spinal muscular atrophy: nusinersen clinical trial experience.","volume":"31","author":"Hach\u00e9","year":"2016","journal-title":"J. Child Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron.","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.1605731113","article-title":"Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.","volume":"113","author":"Hammond","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B102","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S1474-4422(17)30163-1","article-title":"Edaravone: a new treatment for ALS on the horizon?","volume":"16","author":"Hardiman","year":"2017","journal-title":"Lancet Neurol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical diagnosis and management of amyotrophic lateral sclerosis.","volume":"7","author":"Hardiman","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.nmd.2015.05.008","article-title":"The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy.","volume":"25","author":"Harris","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"B105","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/mt.2010.271","article-title":"CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.","volume":"19","author":"Henriques","year":"2011","journal-title":"Mol. Ther."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2010.00032","article-title":"Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?","volume":"4","author":"Henriques","year":"2010","journal-title":"Front. Neurosci."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1177\/1073858417705059","article-title":"The actin cytoskeleton in SMA and ALS: how does it contribute to motoneuron degeneration?","author":"Hensel","year":"2017","journal-title":"Neuroscientist"},{"key":"B108","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ajhg.2016.07.014","article-title":"The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA phenotype.","volume":"99","author":"Hosseinibarkooie","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07468-2","article-title":"TIA1 is a gender-specific disease modifier of a mild mouse model of spinal muscular atrophy.","volume":"7","author":"Howell","year":"2017","journal-title":"Sci. Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1101\/gad.256644.114","article-title":"Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models.","volume":"29","author":"Hua","year":"2015","journal-title":"Genes Dev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"B112","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.","volume":"82","author":"Hua","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"B114","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.febslet.2004.07.010","article-title":"Survival motor neuron protein facilitates assembly of stress granules.","volume":"572","author":"Hua","year":"2004","journal-title":"FEBS Lett."},{"key":"B115","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function.","volume":"24","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/genes8020051","article-title":"Viral Vector-Mediated Antisense therapy for genetic diseases.","volume":"8","author":"Imbert","year":"2017","journal-title":"Genes"},{"key":"B118","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1093\/hmg\/ddt262","article-title":"Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis.","volume":"22","author":"Ishihara","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B119","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.expneurol.2008.07.017","article-title":"Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice.","volume":"213","author":"Ito","year":"2008","journal-title":"Exp. Neurol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/gt.2017.46","article-title":"Developmental regulation of SMN expression: pathophysiological implications and perspectives for therapy development in spinal muscular atrophy.","volume":"24","author":"Jablonka","year":"2017","journal-title":"Gene Ther."},{"key":"B121","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of toxicity from ALS\/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs.","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"B122","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis.","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI72017","article-title":"Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.","volume":"124","author":"Kariya","year":"","journal-title":"J. Clin. Invest."},{"key":"B124","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1093\/hmg\/dds174","article-title":"Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.","volume":"21","author":"Kariya","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B125","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/21678421.2014.907319","article-title":"Nuclear localization of SMN and FUS is not altered in fibroblasts from patients with sporadic ALS.","volume":"15","author":"Kariya","year":"","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B126","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.23","article-title":"A short antisense oligonucleotide ameliorates symptoms of severe mouse models of spinal muscular atrophy.","volume":"3","author":"Keil","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B128","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CND.0b013e318183e0fa","article-title":"Low bone mineral density in spinal muscular atrophy.","volume":"10","author":"Khatri","year":"2008","journal-title":"J .Clin. Neuromuscul. Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis.","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"B130","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/hum.2005.16.509","article-title":"GDNF delivery using human neural progenitor cells in a rat model of ALS.","volume":"16","author":"Klein","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","article-title":"Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice.","volume":"22","author":"Koval","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/379657","article-title":"Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.","volume":"2012","author":"Krakora","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/mt.2013.108","article-title":"Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.","volume":"21","author":"Krakora","year":"2013","journal-title":"Mol. Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.","volume":"10","author":"Kriz","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-3271-9_6","article-title":"Tissue-specific promoters in the CNS.","volume":"1382","author":"K\u00fcgler","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1093\/hmg\/ddr288","article-title":"Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice.","volume":"20","author":"Kwon","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1093\/hmg\/ddr275","article-title":"Temporal requirement for high SMN expression in SMA mice.","volume":"20","author":"Le","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B139","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.","volume":"14","author":"Le","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.celrep.2013.10.049","article-title":"Hexanucleotide repeats in ALS\/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic.","volume":"5","author":"Lee","year":"2013","journal-title":"Cell Rep."},{"key":"B142","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene.","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"B143","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy.","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat. Genet."},{"key":"B144","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1517\/17425247.2012.689285","article-title":"Cell-penetrating peptides for the delivery of nucleic acids.","volume":"9","author":"Lehto","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"B145","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.brainres.2007.09.034","article-title":"Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS.","volume":"1185","author":"Lepore","year":"2007","journal-title":"Brain Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuroscience.2017.10.001","article-title":"Slow intrathecal injection of rAAVrh10 enhances its transduction of spinal cord and therapeutic efficacy in a mutant SOD1 model of ALS.","volume":"365","author":"Li","year":"2017","journal-title":"Neuroscience"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0335-z","article-title":"Intramuscular delivery of scAAV9-hIGF1 prolongs survival in the hSOD1G93A ALS mouse model via upregulation of D-amino acid oxidase.","author":"Lin","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"B149","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","article-title":"Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease.","volume":"22","author":"Lino","year":"2002","journal-title":"J. Neurosci."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-38","article-title":"Sodium vanadate combined with L-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice with spinal muscular atrophy.","volume":"11","author":"Liu","year":"2013","journal-title":"BMC Med."},{"key":"B151","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","article-title":"A novel nuclear structure containing the survival of motor neurons protein.","volume":"15","author":"Liu","year":"1996","journal-title":"EMBO J."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0092-8674(00)80367-0","article-title":"The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.","volume":"90","author":"Liu","year":"1997","journal-title":"Cell"},{"key":"B153","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21152","article-title":"Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.","volume":"62","author":"Locatelli","year":"2007","journal-title":"Ann. Neurol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.mt.6300377","article-title":"Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles.","volume":"16","author":"Lorain","year":"2008","journal-title":"Mol. Ther."},{"key":"B155","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis.","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1523\/JNEUROSCI.1877-07.2007","article-title":"Mutant Cu\/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.","volume":"27","author":"Lu","year":"2007","journal-title":"J. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/17482960903545334","article-title":"Guidelines for preclinical animal research in ALS\/MND: a consensus meeting.","volume":"11","author":"Ludolph","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"B159","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1172\/JCI57291","article-title":"Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy.","volume":"121","author":"Lutz","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B160","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.neuron.2017.07.025","article-title":"TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics.","volume":"95","author":"Mackenzie","year":"2017","journal-title":"Neuron"},{"key":"B161","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann. Neurol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1007\/s12035-016-9850-1","article-title":"C9ORF72 regulates stress granule formation and its deficiency impairs stress granule assembly, hypersensitizing cells to stress.","volume":"54","author":"Maharjan","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.nbd.2016.07.023","article-title":"Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1G93A ALS mice and after partial muscle denervation.","volume":"95","author":"Mancuso","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10476.1","article-title":"What causes amyotrophic lateral sclerosis?","volume":"6","author":"Martin","year":"","journal-title":"F1000Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/21678421.2017.1349151","article-title":"The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.","volume":"18","author":"Martin","year":"","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B166","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1523\/JNEUROSCI.0204-12.2012","article-title":"Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.","volume":"32","author":"Martinez","year":"2012","journal-title":"J. Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.","volume":"60","author":"McAndrew","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy.","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"B170","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/hmg\/ddn382","article-title":"Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.","volume":"18","author":"Meyer","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B171","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ana.20453","article-title":"Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.","volume":"57","author":"Miller","year":"2005","journal-title":"Ann. Neurol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02195-0","article-title":"Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice.","volume":"7","author":"Mirra","year":"2017","journal-title":"Sci. Rep."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(14)70129-2","article-title":"Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?","volume":"13","author":"Mitsumoto","year":"2014","journal-title":"Lancet Neurol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"880","DOI":"10.15252\/emmm.201607298","article-title":"DOK7 gene therapy enhances motor activity and life span in ALS model mice.","volume":"9","author":"Miyoshi","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.gde.2017.01.006","article-title":"Genetic models of C9orf72: what is toxic?","volume":"44","author":"Moens","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1089\/10430349950017536","article-title":"Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis.","volume":"10","author":"Mohajeri","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"B178","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuroscience.2014.05.045","article-title":"Targeting the motor end plates in the mouse hindlimb gives access to a greater number of spinal cord motor neurons: an approach to maximize retrograde transport.","volume":"274","author":"Mohan","year":"2014","journal-title":"Neuroscience"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00252","article-title":"ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.","volume":"8","author":"Moloney","year":"2014","journal-title":"Front. Neurosci."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.","volume":"8","author":"Monani","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B181","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00401-013-1088-7","article-title":"hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive\/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations.","volume":"125","author":"Mori","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1212\/01.wnl.0000200048.53766.b4","article-title":"A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia.","volume":"66","author":"Morita","year":"2006","journal-title":"Neurology"},{"key":"B183","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/hum.2013.186","article-title":"Gene therapy: a promising approach to treating spinal muscular atrophy.","volume":"25","author":"Mulcahy","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"B184","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26-28 June 1992, Bonn, Germany).","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00076","article-title":"Biology of adeno-associated viral vectors in the central nervous system.","volume":"7","author":"Murlidharan","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/mt.2013.115","article-title":"Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.","volume":"21","author":"Nanou","year":"2013","journal-title":"Mol. Ther."},{"key":"B187","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition.","volume":"64","author":"Narver","year":"2008","journal-title":"Ann. Neurol."},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00442","article-title":"The enigmatic role of C9ORF72 in autophagy.","volume":"11","author":"Nassif","year":"2017","journal-title":"Front. Neurosci."},{"key":"B189","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"B190","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00401-017-1708-8","article-title":"Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.","volume":"133","author":"Nijssen","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00018-011-0881-5","article-title":"Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.","volume":"69","author":"Nizzardo","year":"2012","journal-title":"Cell Mol. Life. Sci."},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/srep21301","article-title":"Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype.","volume":"6","author":"Nizzardo","year":"2016","journal-title":"Sci. Rep."},{"key":"B193","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clinthera.2014.02.004","article-title":"Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy \u03947 mouse model phenotype.","volume":"36","author":"Nizzardo","year":"2014","journal-title":"Clin. Ther."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/mt.2016.152","article-title":"Somatic therapy of a mouse SMA model with a U7 snRNA gene correcting SMN2 splicing.","volume":"24","author":"Odermatt","year":"2016","journal-title":"Mol. Ther."},{"key":"B195","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","article-title":"Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.","volume":"17","author":"Oeckl","year":"2016","journal-title":"Amyotroph. Lateral Scler. Frontotemporal. Degener."},{"key":"B196","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1093\/hmg\/ddu198","article-title":"Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models.","volume":"23","author":"Osman","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B197","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/JND-170230","article-title":"Analysis of azithromycin monohydrate as a single or a combinatorial therapy in a mouse model of severe spinal muscular atrophy.","volume":"4","author":"Osman","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"B198","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/mt.2013.276","article-title":"Dual masking of specific negative splicing regulatory elements resulted in maximal exon 7 inclusion of SMN2 gene.","volume":"22","author":"Pao","year":"2013","journal-title":"Mol. Ther."},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.","volume":"3","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.","volume":"120","author":"Passini","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B201","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mt.2013.239","article-title":"Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.","volume":"22","author":"Patel","year":"2014","journal-title":"Mol. Ther."},{"key":"B202","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1242\/dmm.015719","article-title":"Fishing for causes and cures of motor neuron disorders.","volume":"7","author":"Patten","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"B203","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1083\/jcb.152.1.75","article-title":"A functional interaction between the survival motor neuron complex and RNA polymerase II.","volume":"152","author":"Pellizzoni","year":"2001","journal-title":"J. Cell Biol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.1074962","article-title":"Essential role for the SMN complex in the specificity of snRNP assembly.","volume":"298","author":"Pellizzoni","year":"2002","journal-title":"Science"},{"key":"B205","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1093\/hmg\/ddw247","article-title":"Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.","volume":"25","author":"Perera","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","article-title":"Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.","volume":"14","author":"Polymenidou","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse.","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B209","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1523\/JNEUROSCI.21-10-03369.2001","article-title":"Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.","volume":"21","author":"Pramatarova","year":"2001","journal-title":"J. Neurosci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bpa.12352","article-title":"Non-neuronal cells in ALS: role of glial, immune cells and blood-CNS barriers.","volume":"26","author":"Puentes","year":"2016","journal-title":"Brain Pathol."},{"key":"B211","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1205","article-title":"Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.","volume":"11","author":"Ralph","year":"2005","journal-title":"Nat. Med."},{"key":"B212","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuropharm.2013.10.003","article-title":"Spinal inhibitory circuits and their role in motor neuron degeneration.","volume":"82","author":"Ram\u00edrez-Jarqu\u00edn","year":"2014","journal-title":"Neuropharmacology"},{"key":"B213","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","article-title":"Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.","volume":"11","author":"Raoul","year":"2005","journal-title":"Nat. Med."},{"key":"B214","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","article-title":"Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury.","volume":"13","author":"Reaume","year":"1996","journal-title":"Nat. Genet."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.15252\/embj.201593791","article-title":"Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants.","volume":"35","author":"Reber","year":"2016","journal-title":"EMBO J."},{"key":"B216","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.20191","article-title":"Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.","volume":"77","author":"Rembach","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"B217","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics.","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B218","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"B219","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1124\/jpet.113.212407","article-title":"Pharmacology of a central nervous system delivered 2\u2032-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates.","volume":"350","author":"Rigo","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B220","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.nmd.2011.10.012","article-title":"Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.","volume":"22","author":"Rindt","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"B221","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","article-title":"Prevalence and patterns of cognitive impairment in sporadic ALS.","volume":"65","author":"Ringholz","year":"2005","journal-title":"Neurology"},{"key":"B222","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390100473","article-title":"SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens.","volume":"108","author":"Rochette","year":"2001","journal-title":"Hum. Genet."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.celrep.2017.01.035","article-title":"Single-cell analysis of SMN reveals its broader role in neuromuscular disease.","volume":"18","author":"Rodriguez-Muela","year":"2017","journal-title":"Cell Rep."},{"key":"B224","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"B225","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13311-014-0332-8","article-title":"Challenges in the understanding and treatment of amyotrophic lateral sclerosis\/motor neuron disease.","volume":"12","author":"Rosenfeld","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B226","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature14580","article-title":"Genetic compensation induced by deleterious mutations but not gene knockdowns.","volume":"524","author":"Rossi","year":"2015","journal-title":"Nature"},{"key":"B227","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons.","volume":"163","author":"Rossoll","year":"2003","journal-title":"J. Cell Biol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jmg.2008.057950","article-title":"Congenital heart disease is a feature of severe infantile spinal muscular atrophy.","volume":"45","author":"Rudnik-Sch\u00f6neborn","year":"2008","journal-title":"J. Med. Genet."},{"key":"B229","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1093\/brain\/awt097","article-title":"Is SOD1 loss of function involved in amyotrophic lateral sclerosis?","volume":"136","author":"Saccon","year":"2013","journal-title":"Brain"},{"key":"B230","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/hum.2011.200","article-title":"Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates.","volume":"23","author":"Samaranch","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"B231","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/14712598.2015.1044894","article-title":"Current developments in gene therapy for amyotrophic lateral sclerosis.","volume":"15","author":"Scarrott","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"B232","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.15252\/embj.201592559","article-title":"Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.","volume":"35","author":"Scekic-Zahirovic","year":"2016","journal-title":"EMBO J."},{"key":"B233","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/gt.2017.45","article-title":"Therapeutic approaches for spinal muscular atrophy (SMA).","volume":"24","author":"Scoto","year":"2017","journal-title":"Gene Ther."},{"key":"B234","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS.","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"B235","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/nat.2016.0652","article-title":"Identification of a peptide for systemic brain delivery of a morpholino oligonucleotide in mouse models of spinal muscular atrophy.","volume":"27","author":"Shabanpoor","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"B236","doi-asserted-by":"publisher","first-page":"16325","DOI":"10.1073\/pnas.1003459107","article-title":"Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice.","volume":"107","author":"Shan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1212\/WNL.0000000000003741","article-title":"Urinary p75ECD: a prognostic, disease progression, and pharmacodynamic biomarker in ALS.","volume":"88","author":"Shepheard","year":"2017","journal-title":"Neurology"},{"key":"B238","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","article-title":"Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron.","volume":"26","author":"Singh","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/gt.2017.34","article-title":"How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy.","volume":"24","author":"Singh","year":"2017","journal-title":"Gene Ther."},{"key":"B240","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1128\/MCB.00945-10","article-title":"TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy.","volume":"31","author":"Singh","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"B241","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbagrm.2016.12.008","article-title":"Diverse role of survival motor neuron protein.","volume":"1860","author":"Singh","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"B242","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/hmg\/ddt477","article-title":"Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy.","volume":"23","author":"Sleigh","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B243","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1242\/dmm.007245","article-title":"The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.","volume":"4","author":"Sleigh","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"B244","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2012.08.008","article-title":"Spinal muscular atrophy at the crossroads of basic science and therapy.","volume":"23","author":"Sleigh","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"B245","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease.","volume":"116","author":"Smith","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B246","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ana.24549","article-title":"Vascular defects and spinal cord hypoxia in spinal muscular atrophy.","volume":"79","author":"Somers","year":"2016","journal-title":"Ann. Neurol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"B248","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ana.24618","article-title":"Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.","volume":"79","author":"Stoica","year":"2016","journal-title":"Ann. Neurol."},{"key":"B249","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat. Neurosci."},{"key":"B250","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mcn.2007.03.007","article-title":"TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein.","volume":"35","author":"Strong","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"B251","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/21678421.2016.1259334","article-title":"Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis.","volume":"18","author":"Sufit","year":"2017","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B252","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1093\/hmg\/ddp253","article-title":"Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.","volume":"18","author":"Sumner","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7171","article-title":"ALS-causative mutations in FUS\/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.","volume":"6","author":"Sun","year":"2015","journal-title":"Nat. Commun."},{"key":"B254","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol. Ther."},{"key":"B255","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/brain\/awr296","article-title":"Familial versus sporadic amyotrophic lateral sclerosis\u2013a false dichotomy?","volume":"134","author":"Talbot","year":"2011","journal-title":"Brain"},{"key":"B256","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism.","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"B257","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/gt.2017.9","article-title":"Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects.","volume":"24","author":"Thomsen","year":"2017","journal-title":"Gene Ther."},{"key":"B258","doi-asserted-by":"publisher","first-page":"15587","DOI":"10.1523\/JNEUROSCI.2037-14.2014","article-title":"Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.","volume":"34","author":"Thomsen","year":"2014","journal-title":"J. Neurosci."},{"key":"B259","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","article-title":"Disease mechanisms and therapeutic approaches in spinal muscular atrophy.","volume":"35","author":"Tisdale","year":"2015","journal-title":"J. Neurosci."},{"key":"B260","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.nmd.2017.05.011","article-title":"Spinal muscular atrophy: a changing phenotype beyond the clinical trials.","volume":"27","author":"Tizzano","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00058","article-title":"Targeting the full length of the motor end plate regions in the mouse forelimb increases the uptake of fluoro-gold into corresponding spinal cord motor neurons.","volume":"4","author":"Tosolini","year":"2013","journal-title":"Front. Neurol."},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1038\/srep33058","article-title":"Targeting motor end plates for delivery of adenoviruses: an approach to maximize uptake and transduction of spinal cord motor neurons.","volume":"6","author":"Tosolini","year":"2016","journal-title":"Sci. Rep."},{"key":"B263","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/mt.2008.73","article-title":"Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.","volume":"16","author":"Towne","year":"2008","journal-title":"Mol. Ther."},{"key":"B264","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/mt.2010.260","article-title":"Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice.","volume":"19","author":"Towne","year":"2011","journal-title":"Mol. Ther."},{"key":"B265","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.nbd.2011.06.021","article-title":"IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice.","volume":"45","author":"Tsai","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B266","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/emmm.201202303","article-title":"Spliceosome integrity is defective in the motor neuron diseases ALS and SMA.","volume":"5","author":"Tsuiji","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"B267","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbd.2017.01.011","article-title":"Spinal muscular atrophy: factors that modulate motor neurone vulnerability.","volume":"102","author":"Tu","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B268","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.neurobiolaging.2013.09.030","article-title":"Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.","volume":"35","author":"Turner","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B269","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1046\/j.1471-4159.2003.02053.x","article-title":"Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice.","volume":"87","author":"Turner","year":"2003","journal-title":"J. Neurochem."},{"key":"B270","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.nbd.2009.03.005","article-title":"Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.","volume":"34","author":"Turner","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B271","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis.","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"13395","DOI":"10.1074\/jbc.M011176200","article-title":"Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator.","volume":"276","author":"Uranishi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy.","volume":"2","author":"Valori","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B274","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1242\/dmm.029058","article-title":"Modelling amyotrophic lateral sclerosis: progress and possibilities.","volume":"10","author":"van Damme","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"B275","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00001756-200206120-00018","article-title":"Minocycline delays disease onset and mortality in a transgenic model of ALS.","volume":"13","author":"van den Bosch","year":"2002","journal-title":"Neuroreport"},{"key":"B276","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng.3622","article-title":"Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.","volume":"48","author":"van Rheenen","year":"2016","journal-title":"Nat. Genet."},{"key":"B277","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1002\/jcb.24234","article-title":"Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis.","volume":"113","author":"van Zundert","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"B278","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/brain\/awl030","article-title":"Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.","volume":"129","author":"Vance","year":"2006","journal-title":"Brain"},{"key":"B279","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"B280","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/01.wnl.0000174472.03292.dd","article-title":"SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.","volume":"65","author":"Veldink","year":"2005","journal-title":"Neurology"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","article-title":"A multi-source approach to determine SMA incidence and research ready population.","volume":"264","author":"Verhaart","year":"","journal-title":"J. Neurol."},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.","volume":"12","author":"Verhaart","year":"","journal-title":"Orphanet. J. Rare Dis."},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065646","article-title":"Glial promoter selectivity following AAV-delivery to the immature brain.","volume":"8","author":"von Jonquieres","year":"2013","journal-title":"PLOS ONE"},{"key":"B284","doi-asserted-by":"publisher","first-page":"15845","DOI":"10.1074\/jbc.M800834200","article-title":"Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B285","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/hmg\/ddt454","article-title":"Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.","volume":"23","author":"Wang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B286","doi-asserted-by":"publisher","first-page":"13583","DOI":"10.1073\/pnas.212483099","article-title":"Higher order arrangement of the eukaryotic nuclear bodies.","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B287","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","article-title":"Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.","volume":"22","author":"Wang","year":"2002","journal-title":"J. Neurosci."},{"key":"B288","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.nbd.2009.05.002","article-title":"The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis.","volume":"35","author":"Wang","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B289","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s11064-016-2131-6","article-title":"Intrathecal delivery of ssAAV9-DAO extends survival in SOD1G93A ALS mice.","volume":"42","author":"Wang","year":"2017","journal-title":"Neurochem. Res."},{"key":"B290","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jns.2014.02.026","article-title":"SMN1 duplications contribute to sporadic amyotrophic lateral sclerosis susceptibility: evidence from a meta-analysis.","volume":"340","author":"Wang","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"B291","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2016.06.043","article-title":"scAAV9-VEGF prolongs the survival of transgenic ALS mice by promoting activation of M2 microglia and the PI3K\/Akt pathway.","author":"Wang","year":"2016","journal-title":"Brain Res."},{"key":"B292","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamaneurol.2013.593","article-title":"SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy.","volume":"70","author":"Winer","year":"2013","journal-title":"JAMA Neurol."},{"key":"B293","doi-asserted-by":"publisher","first-page":"E1509","DOI":"10.1073\/pnas.1616521114","article-title":"Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy.","volume":"114","author":"Woo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B294","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety, and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.","volume":"16","year":"2017","journal-title":"Lancet Neurol."},{"key":"B295","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1089\/ARS.2009.2618","article-title":"Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.","volume":"11","author":"Wu","year":"2009","journal-title":"Antioxid. Redox. Signal."},{"key":"B296","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"key":"B297","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.celrep.2012.08.025","article-title":"FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.","volume":"2","author":"Yamazaki","year":"2012","journal-title":"Cell Rep."},{"key":"B298","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/17482960600881870","article-title":"Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study).","volume":"7","author":"Yoshino","year":"2006","journal-title":"Amyotroph. Lateral Scler."},{"key":"B299","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1093\/nar\/gkv157","article-title":"U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish.","volume":"43","author":"Yu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B300","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.23-16-06627.2003","article-title":"Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization.","volume":"23","author":"Zhang","year":"2003","journal-title":"J. Neurosci."},{"key":"B301","doi-asserted-by":"publisher","first-page":"19348","DOI":"10.1073\/pnas.1319280110","article-title":"Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy.","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B302","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1093\/hmg\/ddv329","article-title":"Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response.","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B303","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature01031","article-title":"Comprehensive proteomic analysis of the human spliceosome.","volume":"419","author":"Zhou","year":"2002","journal-title":"Nature"},{"key":"B304","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"B305","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.bbrc.2007.10.096","article-title":"SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity.","volume":"364","author":"Zou","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnmol.2017.00405\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T16:20:48Z","timestamp":1570465248000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnmol.2017.00405\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":305,"alternative-id":["10.3389\/fnmol.2017.00405"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2017.00405","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]},"article-number":"405"}}